Institut Català de la Salut
[Trottet C] Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland. ETH AI Center, Zurich, Switzerland. [Schürch M] Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA. [Allam A] Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland. [Petelytska L] Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Department of Internal Medicine #3, Bogomolets National Medical University, Kyiv, Ukraine. [Castellví I] Department of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Bečvář R] Institute of Rheumatology, Department of Rheumatology, 1st Medical School, Charles University, Prague, Czech Republic. [Simeón-Aznar CP] Unitat de Malalties Autoimmunes Sistèmiques, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-11-05T13:43:48Z
2025-11-05T13:43:48Z
2025-09-01
Systemic sclerosis trajectories
Esclerosi sistèmica multiorgànica
Esclerosis sistémica multiorgánica
Systemic sclerosis (SSc) is a chronic autoimmune disease with multi-organ involvement. Historically, SSc classification has focused on the type of skin involvement (limited versus diffuse); however, a growing evidence of organ-specific variability suggests the presence of more than two distinct subtypes. We propose a semi-supervised generative deep learning framework leveraging expert-driven definitions of organ-specific involvement and severity. We model SSc disease trajectories in the European Scleroderma Trials and Research (EUSTAR) database, containing 14,000 patients across 67,000 medical visits, and identify clinically meaningful subtypes to enhance patient stratification and prognosis. We systematically evaluate the model’s predictive accuracy, robustness to missing data, and clinical interpretability. We identified five patient clusters, separating patients based on the degree of organ involvement. Notably, a subset with limited skin involvement still showed high risks of lung and heart complications, underscoring the importance of data-driven methods and multi-organ models to complement established insights from clinical practice.
Article
Versió publicada
Anglès
Aprenentatge profund; Esclerosi sistemàtica progressiva - Classificació; DISEASES::Skin and Connective Tissue Diseases::Connective Tissue Diseases::Scleroderma, Systemic; Other subheadings::Other subheadings::/classification; PHENOMENA AND PROCESSES::Mathematical Concepts::Algorithms::Artificial Intelligence::Machine Learning::Deep Learning; ENFERMEDADES::enfermedades de la piel y tejido conjuntivo::enfermedades del tejido conjuntivo::esclerodermia sistémica; Otros calificadores::Otros calificadores::/clasificación; FENÓMENOS Y PROCESOS::conceptos matemáticos::algoritmos::inteligencia artificial::aprendizaje automático::aprendizaje profundo
Nature Portfolio
npj Digital Medicine;8
https://doi.org/10.1038/s41746-025-01962-y
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HVH [3396]